share_log

維亞生物：董事會會議日期

VIVA BIOTECH: DATE OF BOARD MEETING

香港交易所 ·  Mar 18 04:31
Summary by Moomoo AI
維亞生物科技控股集團（「維亞生物」）將於2024年3月28日（星期四）召開董事會會議，屆時將考慮及批准截至2023年12月31日止年度的全年業績報告及其發佈。會議同時將考慮是否建議派付末期股息。維亞生物的董事會成員包括三名執行董事、兩名非執行董事以及三名獨立非執行董事。董事會主席兼首席執行官為毛晨先生。
維亞生物科技控股集團（「維亞生物」）將於2024年3月28日（星期四）召開董事會會議，屆時將考慮及批准截至2023年12月31日止年度的全年業績報告及其發佈。會議同時將考慮是否建議派付末期股息。維亞生物的董事會成員包括三名執行董事、兩名非執行董事以及三名獨立非執行董事。董事會主席兼首席執行官為毛晨先生。
VIA BIOTECHNOLOGY HOLDINGS GROUP (“VIA BIO”) WILL HOLD A BOARD MEETING ON THURSDAY, 28 MARCH 2024, AT WHICH TIME THE ANNUAL RESULTS REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 AND ITS PUBLICATION WILL BE CONSIDERED AND APPROVED. The meeting will also consider whether to propose a final dividend. Via Bio's board members consist of three executive directors, two non-executive directors and three independent non-executive directors. Chairman of the Board and Chief Executive Officer is Mr. Mao Chen.
VIA BIOTECHNOLOGY HOLDINGS GROUP (“VIA BIO”) WILL HOLD A BOARD MEETING ON THURSDAY, 28 MARCH 2024, AT WHICH TIME THE ANNUAL RESULTS REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 AND ITS PUBLICATION WILL BE CONSIDERED AND APPROVED. The meeting will also consider whether to propose a final dividend. Via Bio's board members consist of three executive directors, two non-executive directors and three independent non-executive directors. Chairman of the Board and Chief Executive Officer is Mr. Mao Chen.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more